A Phase II, Open Label Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Reduction in overall fatigue as measured by Bruera global fatigue severity scale.
Within 4 days after completion of intervention (28 days of Red Bull™)
No
Neil Fleshner, MD, FRCSC, MPH
Principal Investigator
University Health Network, Toronto
Canada: University Health Network Research Ethics Board
12-5041-C
NCT01669460
July 2012
Name | Location |
---|